Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.3517
-0.0293 (-7.69%)
Mar 31, 2025, 1:24 PM EDT - Market open
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $21.86 million as of March 31, 2025. Its market cap has decreased by -69.04% in one year.
Market Cap
21.86M
Enterprise Value
-27.60M
1-Year Change
-69.04%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $21.86M, a decrease of -97.72%. That is a compound annual growth rate of -52.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 23.68M | -32.40% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |